203 related articles for article (PubMed ID: 24972972)
21. AC133 expression associated with poor prognosis in stage II colorectal cancer.
Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
23. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
24. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
25. Expression of MSP58 in human colorectal cancer and its correlation with prognosis.
Shi H; Li SJ; Zhang B; Liu HL; Chen CS
Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
28. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
29. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.
Paik JH; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
BMC Cancer; 2014 Dec; 14():911. PubMed ID: 25472725
[TBL] [Abstract][Full Text] [Related]
32. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
Gaber A; Johansson M; Stenman UH; Hotakainen K; Pontén F; Glimelius B; Bjartell A; Jirström K; Birgisson H
Br J Cancer; 2009 May; 100(10):1540-8. PubMed ID: 19384300
[TBL] [Abstract][Full Text] [Related]
33. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma.
Koresawa R; Yamazaki K; Oka D; Fujiwara H; Nishimura H; Akiyama T; Hamasaki S; Wada H; Sugihara T; Sadahira Y
Br J Haematol; 2016 Jul; 174(2):264-74. PubMed ID: 27061580
[TBL] [Abstract][Full Text] [Related]
35. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
[TBL] [Abstract][Full Text] [Related]
36. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
38. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
Yuan LW; Liu DC; Yang ZL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
[TBL] [Abstract][Full Text] [Related]
39. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]